Decibel Therapeutics (DBTX)
NASDAQ:DBTX

Decibel Therapeutics Stock Analysis & Ratings

DBTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.83 - $9.75
Previous Close$2.24
Volume100.00
Average Volume (3M)64.68K
Market Cap$60.66M
P/E Ratio-1.0
Beta0.45
Next EarningsAug 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-2.17


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

DBTX FAQ

What was Decibel Therapeutics’s price range in the past 12 months?
Decibel Therapeutics lowest stock price was $1.83 and its highest was $9.75 in the past 12 months.
    What is Decibel Therapeutics’s market cap?
    Decibel Therapeutics’s market cap is $60.66M.
      What is Decibel Therapeutics’s price target?
      The average price target for Decibel Therapeutics is $16.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $23.00 ,the lowest forecast is $7.00. The average price target represents 558.44% Increase from the current price of $2.43.
        What do analysts say about Decibel Therapeutics?
        Decibel Therapeutics’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is Decibel Therapeutics’s upcoming earnings report date?
          Decibel Therapeutics’s upcoming earnings report date is Aug 09, 2022 which is in 82 days.
            How were Decibel Therapeutics’s earnings last quarter?
            Decibel Therapeutics released its earnings results on May 12, 2022. The company reported -$0.56 earnings per share for the quarter, missing the consensus estimate of -$0.555 by -$0.005.
              Is Decibel Therapeutics overvalued?
              According to Wall Street analysts Decibel Therapeutics’s price is currently Undervalued.
                Does Decibel Therapeutics pay dividends?
                Decibel Therapeutics does not currently pay dividends.
                What is Decibel Therapeutics’s EPS estimate?
                Decibel Therapeutics’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Decibel Therapeutics have?
                Decibel Therapeutics has 24,960,000 shares outstanding.
                  What happened to Decibel Therapeutics’s price movement after its last earnings report?
                  Decibel Therapeutics reported an EPS of -$0.56 in its last earnings report, missing expectations of -$0.555. Following the earnings report the stock price went up 1.471%.
                    Which hedge fund is a major shareholder of Decibel Therapeutics?
                    Currently, no hedge funds are holding shares in DBTX

                    ---

                    Decibel Therapeutics Stock Analysis

                    The Decibel Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Decibel Therapeutics

                    Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear.

                    ---
                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis